Non-steroidal anti-inflammatory drugs and cancer incidence by sex in the VITamins And Lifestyle (VITAL) cohort
- 3 January 2012
- journal article
- research article
- Published by Springer Science and Business Media LLC in Cancer Causes & Control
- Vol. 23 (3), 431-444
- https://doi.org/10.1007/s10552-011-9891-8
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trialsThe Lancet, 2010
- Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trialsThe Lancet, 2010
- Sex Differences in the Expression of Hepatic Drug Metabolizing EnzymesPublished by American Society for Pharmacology & Experimental Therapeutics (ASPET) ,2009
- Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trialsThe Lancet, 2009
- Association of Nonsteroidal Anti-Inflammatory Drugs with Lung Cancer: Results from a Large Cohort StudyCancer Epidemiology, Biomarkers & Prevention, 2009
- A Large Cohort Study of Nonsteroidal Anti-inflammatory Drug Use and Melanoma IncidenceJNCI Journal of the National Cancer Institute, 2008
- Correlates of circulating C-reactive protein and serum amyloid A concentrations in breast cancer survivorsBreast Cancer Research and Treatment, 2008
- A Large Cohort Study of Long-Term Daily Use of Adult-Strength Aspirin and Cancer IncidenceJNCI Journal of the National Cancer Institute, 2007
- Long-term Use of Aspirin and Nonsteroidal Anti-inflammatory Drugs and Risk of Colorectal CancerJAMA, 2005
- Low-Dose Aspirin in the Primary Prevention of CancerJAMA, 2005